| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Global Head of R&D
1 company
Wang Lai is a President, Global Head of R&D at ONC. Recent filings cover 0 purchases and 46 sales.
Our model assigns Wang Lai a middling insider score of 50/100, based on 27 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -10.2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell10b5-1 | 5,000 | $257.23 | $1,286,174.03 | -100% | -6.5% | +41.8% | |
| Sep 27, 2024 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell10b5-1 | 5,000 | $220.35 | $1,101,774.00 | -100% | -15.4% | +49.3% | |
| Jun 24, 2024 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,064 | $159.80 | $170,029.80 | -100% | +26.5% | +67.6% | |
| Jun 18, 2024 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 2,341 | $157.27 | $368,161.66 | -100% | +27.0% | +63.4% | |
| Jun 26, 2023 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,108 | $181.92 | $201,567.33 | -100% | +5.7% | -16.2% | |
| Jun 20, 2023 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,325 | $192.42 | $254,955.44 | -100% | +9.1% | -18.8% | |
| Jun 7, 2023 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 462 | $224.74 | $103,828.48 | -100% | -8.7% | -29.8% | |
| Jun 27, 2022 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 458 | $177.32 | $81,214.71 | -100% | -23.0% | +5.3% | |
| Jun 21, 2022 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 1,168 | $145.35 | $169,767.41 | -100% | +1.4% | +21.6% | |
| Jun 6, 2022 | ONC Beone Medicines Ltd. | Global Head of R&D | Sell | 660 | $142.00 | $93,717.56 | -100% | +18.1% | +63.4% |